Neurotrophic effects of bone morphogenetic protein-7 in a rat model of Parkinson's disease

Brain Research

Volumn 1022, Issue 1-2, 2004, Pages 88-95

  Harvey, B K ^a   Mark, A ^a   Chou, J ^a   Chen, G J ^a   Hoffer, B J ^a   Wang, Y ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Bone morphogenetic protein 7; Neuroprotection; Parkinson's disease

Indexed keywords

DOPAMINE; METHAMPHETAMINE; OSTEOGENIC PROTEIN 1; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN PROTECTION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINE UPTAKE; DRUG EFFECT; IMMUNOREACTIVITY; MALE; NERVE CELL CULTURE; NEUROPROTECTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SPECIES COMPARISON; SUBSTANTIA NIGRA;

ADRENERGIC AGENTS; ANIMALS; BEHAVIOR, ANIMAL; BONE MORPHOGENETIC PROTEINS; CELL COUNT; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; METHAMPHETAMINE; NERVE GROWTH FACTORS; OXIDOPAMINE; PARKINSON DISEASE; POTASSIUM; RATS; RATS, INBRED F344; TYROSINE 3-MONOOXYGENASE;

EID: 4444279516     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2004.06.072     Document Type: Article

References (34)

1. C.A. Altar, C.B. Boylan, M. Fritsche, B.E. Jones, C. Jackson, S.J. Wiegand, R.M. Lindsay, and C. Hyman Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions J. Neurochem. 63 1994 1021 1032
2. S. Althini, H. Bengtsson, D. Usoskin, S. Soderstrom, A. Kylberg, E. Lindqvist, L.S. Chuva de Sousa, L. Olson, J. Lindeberg, and T. Ebendal Normal nigrostriatal innervation but dopamine dysfunction in mice carrying hypomorphic tyrosine hydroxylase alleles J. Neurosci. Res. 72 2003 444 453
3. H. Bengtsson, S. Soderstrom, A. Kylberg, M.F. Charette, and T. Ebendal Potentiating interactions between morphogenetic protein and neurotrophic factors in developing neurons J. Neurosci. Res. 53 1998 559 568
4. C.V. Borlongan, F.C. Zhou, T. Hayashi, T.P. Su, B.J. Hoffer, and Y. Wang Involvement of GDNF in neuronal protection against 6-OHDA-induced Parkinsonism following intracerebral transplantation of fetal kidney tissues in adult rats Neurobiol. Dis. 8 2001 636 646
5. K.E. Bowenkamp, A.F. Hoffman, G.A. Gerhardt, M.A. Henry, P.T. Biddle, B.J. Hoffer, and A.C. Granholm Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons J. Comp. Neurol. 355 1995 479 489
6. C.F. Chang, S.Z. Lin, Y.H. Chiang, M. Morales, J. Chou, P. Lein, H.L. Chen, B.J. Hoffer, and Y. Wang Intravenous admininstration of bone morphogenetic protein-7 after ischemia improves motor function in stroke rats Stroke 34 2003 558 564
7. C.F. Chang, M. Morales, J. Chou, H.L. Chen, B.J. Hoffer, and Y. Wang Bone morphogenetic proteins are involved in fetal kidney tissue transplantation- induced neuroprotection in stroke rats Neuropharmacology 43 2002 418 426
8. H.L. Chen, P.J. Lein, J.Y. Wang, D. Gash, B.J. Hoffer, and Y.H. Chiang Expression of bone morphogenetic proteins in the brain during normal aging and in 6-hydroxydopamine-lesioned animals Brain Res. 994 2003 81 90
9. Y.H. Chiang, M. Morales, F.C. Zhou, C.V. Borlongan, B.J. Hoffer, and Y. Wang Fetal intranigral ventral mesencephalon and kidney tissue bridge transplantation restores the nigrostriatal dopamine pathway in hemiparkinsonian rats Brain Res. 889 2001 200 207
10. S. Cox, B.K. Harvey, J.F. Sanchez, J.Y. Wang, and Y. Wang Mediation of BMP7 neuroprotection by MAPK and PKC in rat primary cortical cultures Brain Res. 1010 2004 55 61
11. T. Ebendal, H. Bengtsson, and S. Soderstrom Bone morphogenetic proteins and their receptors: potential functions in the brain J. Neurosci. Res. 51 1998 139 146
12. M. Espejo, B. Cutillas, F. Ventura, and S. Ambrosio Exposure of foetal mesencephalic cells to bone morphogenetic protein-2 enhances the survival of dopaminergic neurones in rat striatal grafts Neurosci. Lett. 275 1999 13 16
13. S.S. Gill, N.K. Patel, G.R. Hotton, K. O'Sullivan, R. McCarter, M. Bunnage, D.J. Brooks, C.N. Svendsen, and P. Heywood Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease Nat. Med. 9 2003 589 595
14. B.K. Harvey, C.F. Chang, Y.H. Chiang, W.J. Bowers, M. Morales, H.J. Federoff, B.J. Hoffer, and Y. Wang HSV amplicon delivery of glial cell line-derived neurotrophic factor is neuroprotective against ischemic injury Exp. Neurol. 183 2003 47 55
15. B.J. Hoffer, A. Hoffman, K. Bowenkamp, P. Huettl, J. Hudson, D. Martin, L.F. Lin, and G.A. Gerhardt Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo Neurosci. Lett. 182 1994 107 111
16. J.L. Hudson, C.G. van Horne, I. Stromberg, S. Brock, J. Clayton, J. Masserano, B.J. Hoffer, and G.A. Gerhardt Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats Brain Res. 626 1993 167 174
17. B.S. Jeon, V. Jackson-Lewis, and R.E. Burke 6-Hydroxydopamine lesion of the rat substantia nigra: time course and morphology of cell death Neurodegeneration 4 1995 131 137
18. J. Jordan, M. Bottner, H.J. Schluesener, K. Unsicker, and K. Krieglstein Bone morphogenetic proteins: neurotrophic roles for midbrain dopaminergic neurons and implications of astroglial cells Eur. J. Neurosci. 9 1997 1699 1709
19. C.M. Kearns, W.A. Cass, K. Smoot, R. Kryscio, and D.M. Gash GDNF protection against 6-OHDA: time dependence and requirement for protein synthesis J. Neurosci. 17 1997 7111 7118
20. C.M. Kearns, and D.M. Gash GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo Brain Res. 672 1995 104 111
21. J.Y. Lee, H.C. Koh, M.Y. Chang, C.H. Park, Y.S. Lee, and S.H. Lee Erythropoietin and bone morphogenetic protein 7 mediate ascorbate-induced dopaminergic differentiation from embryonic mesencephalic precursors NeuroReport 14 2003 1401 1404
22. T. Onishi, Y. Ishidou, T. Nagamine, K. Yone, T. Imamura, M. Kato, T.K. Sampath, P. ten Dijke, and T. Sakou Distinct and overlapping patterns of localization of bone morphogenetic protein (BMP) family members and a BMP type II receptor during fracture healing in rats Bone 22 1998 605 612
23. G. Perides, F.E. Jensen, P. Edgecomb, D.C. Rueger, and M.E. Charness Neuroprotective effect of human osteogenic protein-1 in a rat model of cerebral hypoxia/ischemia Neurosci. Lett. 187 1995 21 24
24. T.D. Piscione, T.D. Yager, I.R. Gupta, B. Grinfeld, Y. Pei, L. Attisano, J.L. Wrana, and N.D. Rosenblum BMP-2 and OP1 exert direct and opposite effects on renal branching Am. J. Physiol. 273 1997 F961 F975
25. S. Soderstrom, and T. Ebendal Localized expression of BMP and GDF mRNA in the rodent brain J. Neurosci. Res. 56 1999 482 492
26. M.B. Spina, S.P. Squinto, J. Miller, R.M. Lindsay, and C. Hyman Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system J. Neurochem. 59 1992 99 106
27. L. Studer, C. Spenger, R.W. Seiler, C.A. Altar, R.M. Lindsay, and C. Hyman Comparison of the effects of the neurotrophins on the morphological structure of dopaminergic neurons in cultures of rat substantia nigra Eur. J. Neurosci. 7 1995 223 233
28. A.C. Tomac, A.D. Agulnick, N. Haughey, C.F. Chang, Y. Zhang, C. Backman, M. Morales, M.P. Mattson, Y. Wang, H. Westphal, and B.J. Hoffer Effects of cerebral ischemia in mice deficient in persephin Proc. Natl. Acad. Sci. U. S. A. 99 2002 9521 9526
29. S. Vukicevic, V. Latin, P. Chen, R. Batorsky, A.H. Reddi, and T.K. Sampath Localization of osteogenic protein-1 (bone morphogenetic protein-7) during human embryonic development: high affinity binding to basement membranes Biochem. Biophys. Res. Commun. 198 1994 693 700
30. Y. Wang, C.F. Chang, M. Morales, Y.H. Chiang, T.P. Su, L.I. Tsao, and C. Thiemermann Neuroprotective effects of diadenosine teraphosphate in animal models of stroke and parkinson's disease J. Neurosci. 23 2003 7958 7965
31. Y. Wang, C.F. Chang, M. Morales, J. Chou, H.L. Chen, Y.H. Chiang, S.Z. Lin, J. Cadet, X. Deng, J.Y. Wang, S.Y. Chen, P.L. Kaplan, and B.J. Hoffer Bone morphorgenetic protein-6 reduces ischemia-induced brain damage in rats Stroke 32 2001 2170 2178
32. C. Winkler, H. Sauer, C.S. Lee, and A. Bjorklund Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease J. Neurosci. 16 1996 7206 7215
33. F.C. Zhou, Y.H. Chiang, and Y. Wang Constructing a new nigrostriatal pathway in the Parkinsonian model with bridged neural transplantation in substantia nigra J. Neurosci. 16 1996 6965 6974
34. C.L. Zuch, V.K. Nordstroem, L.A. Briedrick, G.R. Hoernig, A.C. Granholm, and P.C. Bickford Time course of degenerative alterations in nigral dopaminergic neurons following a 6-hydroxydopamine lesion J. Comp. Neurol. 427 2000 440 454